Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depression

Abstract

The multi-drug resistance gene ABCB1 (or MDR1) encodes a P-glycoprotein (P-gp) that regulates passage of many substances across the blood–brain barrier. The antidepressant amitriptyline and its metabolites (including nortriptyline) are substrates for P-gp, and in mice lacking P-gp, penetration of amitriptyline, but not fluoxetine, into the brain is enhanced. We reasoned that polymorphic variation of P-gp may contribute to differing responses of patients to antidepressant drugs. A single nucleotide polymorphism (SNP) of ABCB1 (3435C>T) was recently correlated with expression levels and in vivo function of P-gp. We examined this SNP in patients with major depression enrolled in a randomized antidepressant treatment trial of nortriptyline and fluoxetine, and observed a significant association between nortriptyline-induced postural hypotension and 3435C>T (χ2 = 6.78, df = 2, P = 0.034). Our results suggest that homozygosity for 3435T alleles of ABCB1 is a risk factor for occurrence of nortriptyline-induced postural hypotension (OR = 1.37, P = 0.042, 95% CI 1.01–1.86).

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Uhr M, Steckler T, Yassouridis A, Holsboer F . Penetration of amitriptyline, but not of fluoxetine, into brain is enhanced in mice with blood–brain barrier deficiency due to mdr1a P-glycoprotein gene disruption Neuropsychopharmacology 2000 22: 380–387

    Article  CAS  Google Scholar 

  2. Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmoller J, Johne A et al . Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo Proc Natl Acad Sci USA 2000 97: 3473–3478

    Article  CAS  Google Scholar 

  3. Frazer A . Pharmacology of antidepressants J Clin Psychopharmacol 1997 17: 2S–18S

    Article  CAS  Google Scholar 

  4. Moller HJ . Are all antidepressants the same? J Clin Psychiatry 2000 61: 24–28

    PubMed  Google Scholar 

  5. Tollefson GD . Antidepressant treatment and side effect considerations J Clin Psychiatry 1991 52 Suppl: 4–13

    CAS  PubMed  Google Scholar 

  6. Liu BA, Topper AK, Reeves RA, Gryfe C, Maki BE . Falls among older people: relationship to medication use and orthostatic hypotension J Am Geriatr Soc 1995 43: 1141–1145

    Article  CAS  Google Scholar 

  7. Chen CJ, Clark D, Ueda K, Pastan I, Gottesman MM, Roninson IB . Genomic organization of the human multidrug resistance (MDR1) gene and origin of P-glycoproteins J Biol Chem 1990 265: 506–514

    CAS  PubMed  Google Scholar 

  8. Kioka N, Tsubota J, Kakehi Y, Komano T, Gottesman MM, Pastan I et al . P-glycoprotein gene (MDR1) cDNA from human adrenal: normal P-glycoprotein carries Gly185 with an altered pattern of multidrug resistance Biochem Biophys Res Commun 1989 162: 224–231

    Article  CAS  Google Scholar 

  9. Gottesman MM, Pastan I . Biochemistry of multidrug resistance mediated by the multidrug transporter Annu Rev Biochem 1993 62: 385–427

    Article  CAS  Google Scholar 

  10. Schinkel AH, Smit JJ, van Tellingen O, Beijnen JH, Wagenaar E, van Deemter L et al . Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood–brain barrier and to increased sensitivity to drugs Cell 1994 77: 491–502

    Article  CAS  Google Scholar 

  11. Schinkel AH, Wagenaar E, Mol CA, van Deemter L . P-glycoprotein in the blood–brain barrier of mice influences the brain penetration and pharmacological activity of many drugs J Clin Invest 1996 97: 2517–2524

    Article  CAS  Google Scholar 

  12. Mickley LA, Lee JS, Weng Z, Zhan Z, Alvarez M, Wilson W et al . Genetic polymorphism in MDR-1: a tool for examining allelic expression in normal cells, unselected and drug-selected cell lines, and human tumors Blood 1998 91: 1749–1756

    CAS  PubMed  Google Scholar 

  13. Ito S, Ieiri I, Tanabe M, Suzuki A, Higuchi S, Otsubo K . Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects Pharmacogenetics 2001 11: 175–184

    Article  CAS  Google Scholar 

  14. Hitzl M, Drescher S, van der Kuip H, Schaffeler E, Fischer J, Schwab M et al . The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56(+) natural killer cells Pharmacogenetics 2001 11: 293–298

    Article  CAS  Google Scholar 

  15. Ameyaw MM, Regateiro F, Li T, Liu XH, Tariq M, Mobarek A et al . MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity Pharmacogenetics 2001 11: 217–221

    Article  CAS  Google Scholar 

  16. Roberts R, Joyce P, Kennedy MA . Rapid and comprehensive determination of cytochrome P450 CYP2D6 poor metabolizer genotypes by multiplex polymerase chain reaction Hum Mutat 2000 16: 77–85

    Article  CAS  Google Scholar 

  17. Mathias CJ, Kimber JR . Treatment of postural hypotension J Neurol Neurosurg Psychiatry 1998 65: 285–289

    Article  CAS  Google Scholar 

  18. Verhaeverbeke I, Mets T . Drug-induced orthostatic hypotension in the elderly: avoiding its onset Drug Saf 1997 17: 105–118

    Article  CAS  Google Scholar 

  19. Mathias CJ, Kimber JR . Postural hypotension: causes, clinical features, investigation, and management Annu Rev Med 1999 50: 317–336

    Article  CAS  Google Scholar 

  20. Schoenberger JA . Drug-induced orthostatic hypotension Drug Saf 1991 6: 402–407

    Article  CAS  Google Scholar 

  21. Middleton HC, Maisey DN, Mills IH . Do antidepressants cause postural hypotension by blocking cardiovascular reflexes? Eur J Clin Pharmacol 1987 31: 647–653

    Article  CAS  Google Scholar 

  22. U'Prichard DC, Greenberg DA, Sheehan PP, Snyder SH . Tricyclic antidepressants: therapeutic properties and affinity for alpha-noradrenergic receptor binding sites in the brain Science 1978 199: 197–198

    Article  CAS  Google Scholar 

  23. Cohen MD, Finberg J, Dibner-Dunlap M, Yuih SN, Thames MD . Effects of desipramine hydrochloride on peripheral sympathetic nerve activity Am J Physiol 1990 258: R876–R882

    Article  CAS  Google Scholar 

  24. Cascorbi I, Gerloff T, Johne A, Meisel C, Hoffmeyer S, Schwab M et al . Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects Clin Pharmacol Ther 2001 69: 169–174

    Article  CAS  Google Scholar 

  25. Schaeffeler E, Eichelbaum M, Brinkmann U, Penger A, Asante-Poku S, Zanger UM et al . Frequency of C3435T polymorphism of MDR1 gene in African people Lancet 2001 358: 383–384

    Article  CAS  Google Scholar 

  26. Roose SP, Dalack GW . Treating the depressed patient with cardiovascular problems J Clin Psychiatry 1992 53 Suppl: 25–31

    CAS  PubMed  Google Scholar 

  27. Glassman AH . Cardiovascular effects of tricyclic antidepressants Annu Rev Med 1984 35: 503–511

    Article  CAS  Google Scholar 

  28. Glassman AH, Bigger JT Jr, Giardina EV, Kantor SJ, Perel JM, Davies M . Clinical characteristics of imipramine-induced orthostatic hypotension Lancet 1979 1: 468–472

    Article  CAS  Google Scholar 

  29. Marin J, Rodriguez-Martinez MA . Age-related changes in vascular responses Exp Gerontol 1999 34: 503–512

    Article  CAS  Google Scholar 

  30. Carter JD, Joyce PR, Mulder RT, Luty SE, McKenzie JM . Gender differences in the presentation of depressed outpatients: a comparison of descriptive variables J Affect Disord 2000 61: 59–67

    Article  CAS  Google Scholar 

  31. Luty SE, Joyce PR, Mulder RT, McKenzie JM . Social adjustment in depression: the impact of depression severity, personality and clinic versus community sampling J Affect Disord 2002 (in press)

  32. Joyce PR, Mulder RT, Luty SE, Sullivan PF, McKenzie JM, Abbott RM et al . Patterns and predictors of response, remission and recovery in major depression treated with fluoxetine or nortriptyline Aust NZJ Psychiat 2002 (in press)

  33. Spitzer RL, Williams JB, Gibbon M, First MB . The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description Arch Gen Psychiatry 1992 49: 624–629

    Article  CAS  Google Scholar 

  34. Hamilton M . A rating scale for depression J Neurol Neurosurg Psychiatry 1960 12: 56–62

    Article  Google Scholar 

  35. Montgomery SA, Asberg M . A new depression scale designed to be sensitive to change Br J Psychiatry 1979 134: 382–389

    Article  CAS  Google Scholar 

  36. Braithwaite RA, Widdop B . A specific gas-chromatographic method for the measurement of ‘steady-state’ plasma levels of amitriptyline and nortriptyline in patients Clin Chim Acta 1971 35: 461–472

    Article  CAS  Google Scholar 

  37. Ciulla T, Slar R, Hauser S . A simple method for DNA purification from peripheral blood Anal Biochem 1988 174: 485–488

    Article  CAS  Google Scholar 

  38. Rozen S, Skaletsky H . Primer3 on the WWW for general users and for biologist programmers Methods Mol Biol 2000 132: 365–386

    CAS  PubMed  Google Scholar 

  39. Chen CJ, Chin JE, Ueda K, Clark DP, Pastan I, Gottesman MM et al . Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells Cell 1986 47: 381–389

    Article  CAS  Google Scholar 

  40. Tanabe M, Ieiri I, Nagata N, Inoue K, Ito S, Kanamori Y et al . Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene J Pharmacol Exp Therapeut 2001 297: 1137–1143

    CAS  Google Scholar 

Download references

Acknowledgements

We thank Allison Miller, Isobel Stevens, Robyn Abbott and Dr Sue Luty for contributions to this research. This work was supported by grants from the Health Research Council of New Zealand and Otago University. Rebecca Roberts is a Leslie Averill Fellow of the Canterbury Medical Research Foundation, and Dr Martin Kennedy is a Senior Research Fellow of the Health Research Council of New Zealand.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M A Kennedy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roberts, R., Joyce, P., Mulder, R. et al. A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depression. Pharmacogenomics J 2, 191–196 (2002). https://doi.org/10.1038/sj.tpj.6500099

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.tpj.6500099

Keywords

This article is cited by

Search

Quick links